Rentschler exits cell and gene business due to low demand, will prioritize biologics
German CDMO Rentschler Biopharma is closing down its cell and gene therapy operations and shuttering a facility in the UK, which could affect up to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
